A b s t r a c t
At present, only limited data are available on the characterization of the T cells in Kikuchi lymphadenitis. One report detected an increase of gammadelta T cells in the necrotic area of Kikuchi lymphadenitis. 17 Another report showed that T cells in Kikuchi lymphadenitis had a normal diploid karyotype. 3 To our knowledge, a systematic evaluation of the status of TCR rearrangement has not been done.
To distinguish Kikuchi lymphadenitis from malignant lymphoma and benign conditions, we used nested polymerase chain reaction (PCR) tests followed by high-resolution gel electrophoresis to determine the rearrangement status of T-cell antigen receptors beta and gamma.
Materials and Methods

Cases
We obtained 55 cases of Kikuchi lymphadenitis and 1 case of recurrent lymphadenopathy that also was diagnosed as Kikuchi lymphadenitis. Cervical lymph node biopsies were done at the time of initial examination, and diagnoses were made at the Pathology Department, National Taiwan University Hospital, Taipei, between 1991 and 1999. Clinical data were obtained from the medical records. Ten cases of Southern blot-proven T-cell lymphoma were used as positive controls, and 10 cases of reactive lymph nodes were used as negative controls. These included 2 hyperplastic tonsils, 2 lymph nodes with T-zone hyperplasia, 2 B-cell lymphomas, 2 lymph nodes involved by metastatic carcinoma, 1 tuberculosis lymphadenopathy, and 1 dermatopathic lymphadenopathy.
DNA Extraction
Genomic DNA was extracted from paraffin-embedded tissue blocks by using QIAamp kits (QIAGEN, Valencia, CA). Briefly, a 20-to 60-µm section was mixed with 1 mL of xylene at room temperature for 2 minutes for removal of paraffin. After centrifugation, residual xylene was dissolved in ethanol and removed by evaporation. The deparaffinized tissue was mixed with 180 µL of lysis buffer and 20 µL of Proteinase K at 55°C overnight. After centrifugation, the supernatant containing DNA was saved. The DNA was precipitated by ethanol and redissolved in tris(hydroxymethyl)aminomethane (Tris)-EDTA buffer for future use.
PCR Conditions
Rearrangements of TCR beta and TCR gamma were determined by an initial PCR followed by a nested PCR. All initial PCRs were done in a 20-µL standard reaction mixture containing a 15-mmol/L concentration of Tris hydrochloride (pH 8.0), a 1.5-mmol/L concentration of magnesium chloride, a 50-mmol/L concentration of potassium chloride, a 200-µmol/L concentration of each deoxynucleoside triphosphate, a 0.3-µmol/L concentration of each primer set, 0.1 µg of extracted DNA, and 1 U of Taq polymerase. The standard reaction mixture plus primers and template was subjected to 35 cycles of PCR. The primers used in the PCRs are specified in ❚Table 1❚ and ❚Figure 1❚. Each cycle included denaturation at 94°C for 45 seconds, annealing at 48°C for 45 seconds, and extension at 72°C for 45 seconds. After 35 cycles, 2 µL of the reaction mixture from the initial PCRs was saved and used as the template for the nested PCR, which was done under the same conditions as the initial PCR.
Primers for TCR beta Rearrangement
The TCR beta rearrangement was examined by using nested PCRs, as modified from 2 previous reports. 18, 19 Sequences for all primers are listed in Table 1 . The locations of the primers relative to the genomic structure are shown in Figure 1 . [20] [21] [22] ❚Table 1❚ Polymerase Chain Reaction (PCR) Primers for T-Cell Receptor (TCR) Rearrangement * PCR Sequence
In the initial PCR, 1 consensus primer (V1) was used for annealing to the variable regions of TCR beta, 2 consensus primers (D1 and D2) were used for annealing to the diversity regions, and 7 primers were used for annealing to the junctional regions. Thus, a 20-µL initial PCR contained a 0.3-µmol/L concentration of V1, a 0.15-µmol/L concentration of D1 plus a 0.15-µmol/L concentration of D2, a 0.30-µmol/L concentration of J mixture with equal molar J beta 1 through J beta 7, and 0.1 µg of DNA in the standard reaction mixture.
In the nested PCR, 1 consensus primer (V2) was used for annealing to the variable regions of TCR beta, 2 consensus primers (D3 and D4) were used for annealing to the diversity regions, and 1 fluorescence-labeled primer (J) was used for annealing to the junctional regions. Thus, a 20-µL nested PCR contained a 0.3-µmol/L concentration of V2, a 0.15-µmol/L concentration of D3 plus a 0.15-µmol/L concentration of D4, a 0.30-µmol/L concentration of J, and 2 µL of DNA template from the initial PCR in the standard reaction mixture.
Primers for TCR gamma Rearrangement
The TCR gamma gene locus has a relatively simple structure, consisting of 11 variable segments belonging to 4 groups (Vr I, Vr II, Vr III, and Vr IV), 2 junctional genes (J gamma 1 and J gamma 2), and 3 junctional pseudogenes (J gamma p, J gamma p1, J gamma p2). 23 Since the variable regions of TCR gamma can be categorized by sequence homology into 4 groups, we used 4 group-specific primers to determine the TCR gamma rearrangement status in 4 separate nested PCR reactions. This approach is similar in principle to the approach described in previous publications. 24, 25 Sequences for all primers are listed in Table 1 . The locations of the primers relative to the genomic structure are shown in Figure 1 . [20] [21] [22] For example, an initial 20-µL PCR for the group V1-J rearrangement included a 0.3-µmol/L concentration of variable region-specific primer (V1), a mixture of junctional region primers (J gamma 1/2, J gamma p, J gamma p1/2), and 0.1 µg of extracted DNA in the standard reaction mixture. The nested PCR contained a 0.3-µmol/L concentration of fluorescence-labeled variable region-specific primer (V1'), a mixture of junctional region primers (J gamma 1/2', J gamma p', J gamma p1/2'), and 2 µL of DNA template from the initial PCR in the standard reaction mixture.
Electrophoresis by a High-Resolution DNA Analyzer
For a single case, the 4 PCR reactions for TCR gamma rearrangements were mixed together in equal volumes. The PCR products were separated by electrophoresis on a highresolution DNA analyzer (ABI377 equipped with GeneScan software, Perkin-Elmer, Foster City, CA). This represents an overall status of the TCR gamma rearrangements. The reaction products for TCR beta rearrangements also were separated under the same conditions ❚Figure 2❚.
Analysis for Clonality at the TCR beta or TCR gamma Locus
A case is polyclonal if electrophoresis of the PCR product done on GeneScan yields a continuous normal distribution curve (Figure 2A ). A case is said to have an oligoclonal pattern if discrete multiple peaks are noted ( Figures 2C and 2D ). Sometimes a mixed pattern is noted, for example, polyclonal at the beta locus but oligoclonal at the gamma locus ( Figure 2B ). A case is monoclonal if only 1 peak is noted on GeneScan. This pattern was not found in the present study, except that the only case with recurrent lymphadenopathy had a predominant peak at the gamma locus during recurrence ( Figure 2E ). ❚Figure 1❚ Scheme for the nested polymerase chain reaction of T-cell receptor (TCR) beta and gamma rearrangements. The genomic structure of TCR beta consists of the variable regions (V beta 1-n), the first diversity and junctional regions (D1 and J1), and the second diversity and junctional regions (D2 and J2). For the variable region, the locations of the primers V1 and V2 relative to the consensus sequence are shown. 21 For the diversity and junctional regions, the locations of the primers relative to the genomic sequence are shown. 22 The genomic structure of TCR gamma consists of variable segments (V gamma 1-n) and 5 junction segments. The consensus sequences of the variable and the junctional regions were taken from published data. 21, 23 The locations of the primers relative to the consensus sequences are shown. Note that J gamma 1 and J gamma 2 have similar sequences. They are amplified by the same primers, J gamma 1/2 and J gamma 1/2'. Also J gamma p1 and J gamma p2 had similar sequences and could be amplified by the same primer, J gamma p1/2, then nested by 2 separate primers, J gamma p1' and J gamma p2'. The positions of V gamma I-IV and V gamma I'-IV' relative to the consensus sequence of 375 nucleotides are indicated by the numeric ranges.
Results
Patient Characteristics
The series include 55 cases of Kikuchi lymphadenitis with spontaneous resolution of their lymphadenopathy and 1 case of recurrent lymphadenopathy of unknown cause that also was diagnosed as Kikuchi lymphadenitis.
The 55 cases included 40 female and 15 male patients, with a median age of 28 years (range, 6-53 years). There was no associated systemic autoimmune disease. All 55 patients had a self-limiting course with spontaneous resolution of lymphadenopathy within 6 months with no treatment or only symptomatic treatment. Representative TCR rearrangement patterns are shown in Figure 2 .
The exceptional case, an 18-year-old man, had multiple episodes of lymphadenopathy requiring corticosteroid treatment to achieve remission. This patient developed bilateral cervical lymphadenopathy, fever, and leukopenia with a leukocyte count of 1,800/µL (1.8 × 10 9 /L). He had no evidence of viral infection or autoimmune disease in extensive serologic tests. The lymphadenopathy and fever subsided, and the leukocyte count rose to 3,200/µL (3.2 × 10 9 /L) within 10 days, without corticosteroid treatment. Similar episodes were repeated 3 times during a 3-month period. Corticosteroid treatment eventually was started, and the lymphadenopathy resolved. Despite the protracted course, the case was diagnosed as Kikuchi lymphadenitis because of typical histopathologic features and the absence of other systemic autoimmune diseases. Figures 2D and 2E show the TCR rearrangement patterns at the time of diagnosis and during recurrence.
TCR Rearrangement
PCR-based tests for TCR rearrangements vary among laboratories. In general, tests for TCR gamma rearrangement are more sensitive but less specific, and tests for TCR beta rearrangement are less sensitive but more specific. 
City, CA) tracings (composite picture) showing a spectrum of increasing oligoclonality (dark, beta; light, gamma). x-axis, size of polymerase chain reaction product; y-axis, relative intensity. An arrowhead indicates a major beta peak, and an asterisk indicates a major gamma peak. A polyclonal pattern is represented by a normal distribution of multiple small peaks, an oligoclonal pattern shows 2 or more major peaks, and a monoclonal pattern shows a single major peak. A, Polyclonal beta and polyclonal gamma. B, Polyclonal beta and oligoclonal gamma. C, Oligoclonal beta and oligoclonal gamma. D and E, T-cell receptor rearrangement in an 18-year-old man with initial cervical lymphadenopathy (D) and recurrence 3 months later (E). Note the increasing oligoclonality as a polyclonal pattern gradually changes to an oligoclonal pattern (from A to C). The only patient with recurrent lymphadenopathy initially had a beta peak superimposed on a polyclonal beta background and an oligoclonal gamma pattern (D), which evolved into an oligoclonal beta pattern and a monoclonal gamma pattern during recurrence (E).
example, in a recent multicenter comparison, 26 the overall sensitivity of PCR-based tests for TCR beta rearrangement was only 47%. The sensitivity for PCR-based tests for TCR gamma rearrangements was 78%, with a false-positive rate of 4%. To increase the sensitivity and specificity, the rearrangements of TCR beta and TCR gamma can be considered together and placed into 4 groups: polyclonal, mixed, oligoclonal, and monoclonal ❚Table 2❚. Most reactive lymphadenopathies had polyclonal T-cell populations (7/10), some had a mixed or oligoclonal pattern (3/10), but none had a monoclonal pattern. Most T-cell lymphomas had a monoclonal population (9/10), and rarely an oligoclonal pattern (1/10). Kikuchi lymphadenopathies frequently had mixed or oligoclonal T-cell populations (47/55 [85%]). A more accurate assessment using the chi-square test on the 4 × 3 contingency table showed a highly significant difference in the distribution of clonality (chi-square = 83.77, df = (4 -1) × (3 -1) = 6, at P = .001).
Looking separately into TCR beta and TCR gamma rearrangements, we found a polyclonal pattern of TCR beta rearrangement in 28 (51%) of 55 cases. In the remaining 27 cases (49%), the pattern was oligoclonal to variable degrees, and a monoclonal pattern was not found. For the gamma rearrangement, a true polyclonal pattern was found in only 8 (15%) of 55 cases, and all 8 cases had a polyclonal TCR beta rearrangement. The remaining 47 cases (85%) showed an oligoclonal pattern. Representative tracings from GeneScan are shown in Figure 2 .
Correlation of TCR Rearrangement Status With Clinical Manifestations
As shown in ❚Table 3❚, the 55 cases can be classified into group 1 with both polyclonal beta and polyclonal gamma patterns (8 cases), group 2 with a polyclonal beta but an oligoclonal gamma pattern (20 cases), and group 3 with both oligoclonal beta and oligoclonal gamma patterns (27 cases). Typical examples of the rearrangement patterns from the 3 groups are shown in Figures 2A to 2C . The only recurrent case had an oligoclonal pattern at diagnosis ( Figure 2D ). At recurrence, this case showed an oligoclonal pattern at the beta locus and was monoclonal at the gamma locus ( Figure 2E ).
There was an overall 44% incidence (24 cases) of leukopenia (WBC count, <4,000/µL [<4.0 × 10 9 /L]). A 3 × 2 comparison based on the presence or absence of leukopenia in the 3 groups showed a significant difference (chi-square = 7.29, df = (3 -1) × (2 -1) = 2, at P = .026). This is due to a 2.5-fold difference between the mixed and the oligoclonal groups (65% vs 26%). In a previous report based on histopathologic features, 3 Kikuchi lymphadenitis was classified into proliferative, necrotizing, and xanthomatous types, with similar incidences of leukopenia (WBC count, <4,000/µL [<4.0 × 10 9 /L]) at 40.0%, 39.5%, and 46.2%, respectively. The association of leukopenia with a polyclonal T-cell population is thus a new finding, independent of histopathologic changes, and deserves further investigation.
Correlation of TCR Rearrangement Status With Histopathologic Features
In a previous report, Kikuchi lymphadenitis was classified into proliferative, necrotizing, and xanthomatous types based on histopathologic features, with 29% proliferative, 53% necrotizing, and 18% xanthomatous. 3 Review of our 55 cases showed 33% proliferative (18 cases), 38% necrotizing (21 cases), and 29% xanthomatous (16 cases). There was no significant association between T-cell clonality and histopathologic features (chi-square = 1.17; P = .88). Representative histopathologic features of the 3 groups and of the recurrent case are shown in ❚Image 1❚.
Discussion
Kikuchi lymphadenitis is a self-limiting lymphadenopathy of unknown cause, characterized by subcortical patchy necrosis with infiltrating plasmacytoid monocytes and cytotoxic T cells, but no neutrophils. The diagnosis depends mainly on demonstrating the characteristic histopathologic features. [1] [2] [3] However, the morphologic changes of focal necrosis and apoptotic bodies surrounded by lymphohistiocytic infiltrates may overlap with those of T-cell lymphoma and autoimmune disease such as SLE. To resolve the difficult differential diagnosis, we used nested PCR tests followed by high-resolution gel electrophoresis to determine the status of rearrangement of the Tcell antigen receptors beta and gamma. In a series of 55 cases, we found that none had monoclonal TCR beta or TCR gamma rearrangement, supporting a diagnosis of Kikuchi lymphadenitis instead of T-cell lymphoma. However, an oligoclonal beta pattern was detected in about half of the cases, and an even higher proportion of cases showed an oligoclonal pattern of TCR gamma rearrangement.
This high frequency of oligoclonal T-cell populations is alarming to the diagnostic histopathologist, because oligoclonal T-cell populations have been reported to be associated with an early stage of T-cell lymphoma. [27] [28] [29] [30] Furthermore, Kikuchi lymphadenitis might be an autoimmune condition resembling SLE, 12 which, like many other autoimmune diseases, also is associated with an increased incidence of malignant lymphoma. [13] [14] [15] [16] Despite such an association, oligoclonal T cells in Kikuchi lymphadenitis do not evolve into T-cell lymphoma, as evidenced by the spontaneous resolution of the lymphadenopathy in all 55 of our cases within 6 months.
Rather, the high frequency of oligoclonal T-cell populations in Kikuchi lymphadenitis is consistent with a reactive nature. An oligoclonal pattern of TCR beta rearrangement may be present not only in SLE but also in rheumatoid arthritis, viral infection, and certain tumors. [31] [32] [33] [34] [35] [36] [37] It is interesting to note the predominant T cells in the lymph nodes of Kikuchi lymphadenitis are CD8+ cytotoxic T cells, which were even more likely than CD4+ T cells to undergo clonal expansion. 38 This might partially explain the high frequency of oligoclonal T-cell expansion in Kikuchi lymphadenopathy.
A reactive nature against an unknown antigen seems the most likely explanation for the oligoclonal T-cell populations, but we may speculate that a systemic defect in the TCR repertoire or a lymphoproliferative disorder associated with an immunodeficiency state also could account for the oligoclonal T-cell populations. Further study would be required to settle the issue.
Although the cause for the development of an oligoclonal T-cell population and restriction of the TCR repertoire is unknown, we expect that TCR gamma should become restricted earlier in the process than TCR beta, because the variable and junctional segments in the TCR beta locus are more numerous than in the TCR gamma locus. This is indeed the case, as shown by our data; all cases with an oligoclonal beta pattern also had an oligoclonal gamma pattern, but the reverse, an oligoclonal beta pattern with a polyclonal gamma pattern, was not found. The case with recurrent lymphadenopathy is the only one that showed a monoclonal gamma peak. Despite an atypical clinical course, this case was diagnosed as Kikuchi lymphadenitis based on the typical histopathologic features of necrotizing histiocytic lymphadenitis and the absence of serologic markers of other autoimmune diseases. One might argue that this case could be a lymphoma at an early stage of development. Even if this is true, the possibility of an oligoclonal T-cell population evolving into lymphoma is still less than 2% (1/56). Although we do not have long-tern follow-up data, a previous report from Taiwan has shown a low recurrent rate of 3.3%, 3 which is comparable to our result of 2%. Thus, the likelihood of T-cell lymphoma arising from Kikuchi lymphadenitis is small.
Lack of a monoclonal T-cell population in Kikuchi lymphadenitis at the time of initial examination can be used as a diagnostic criterion to exclude the possibility of T-cell lymphoma. As the finding of oligoclonal T cells has been reported in a variety of immune reactions, an oligoclonal T-cell population is most consistent with the reactive nature of the disease, even though the specific causative antigen is still known. 
